Morgan Stanley
ELOX

Morgan Stanley’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Morgan Stanley’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-79
Closed -$380 – 8072
2023
Q3 		$380 Hold
79
– – ﹤0.01% 7336
2023
Q2 		$307 Hold
79
– – ﹤0.01% 7420
2023
Q1 		$198 Sell
79
-1
-1% -$4 ﹤0.01% 7518
2022
Q4 		$146 Buy
80
+1
+1% +$5 ﹤0.01% 7670
2022
Q3 		$1K Sell
79
-1
-1% -$12 ﹤0.01% 7656
2022
Q2 		$1K Sell
80
-61
-43% -$842 ﹤0.01% 7750
2022
Q1 		$3K Buy
141
+49
+53% +$964 ﹤0.01% 7711
2021
Q4 		$2K Buy
92
+72
+360% +$3.14K ﹤0.01% 7834
2021
Q3 		$1K Sell
20
-484
-96% -$29.8K ﹤0.01% 7876
2021
Q2 		$39K Buy
504
+461
+1,072% +$38.5K ﹤0.01% 6775
2021
Q1 		$5K Sell
43
-765
-95% -$117K ﹤0.01% 7132
2020
Q4 		$129K Buy
808
+737
+1,038% +$90.1K ﹤0.01% 5807
2020
Q3 		$8K Sell
71
-1,803
-96% -$216K ﹤0.01% 6347
2020
Q2 		$227K Buy
1,874
+5
+0.3% +$566 ﹤0.01% 5019
2020
Q1 		$147K Sell
1,869
-2,315
-55% -$377K ﹤0.01% 5014
2019
Q4 		$1.23M Buy
4,184
+2,334
+126% +$470K ﹤0.01% 4392
2019
Q3 		$334K Buy
1,850
+223
+14% +$63.4K ﹤0.01% 4876
2019
Q2 		$649K Buy
1,627
+1,542
+1,814% +$649K ﹤0.01% 4461
2019
Q1 		$40K Sell
85
-774
-90% -$376K ﹤0.01% 5764
2018
Q4 		$413K Sell
859
-47
-5% -$25.9K ﹤0.01% 4902
2018
Q3 		$617K Sell
906
-243
-21% -$156K ﹤0.01% 4875
2018
Q2 		$785K Buy
+1,149
New +$745K ﹤0.01% 4782

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Morgan Stanley's ELOX Position: Q4 2023 in Review

Morgan Stanley sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 79 shares — an estimated $380 sold.

Morgan Stanley first reported a position in ELOX in Q2 2018 and held it in 22 quarters. The position peaked at $1.23M in Q4 2019. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Morgan Stanley reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Morgan Stanley sold 79 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $380.
  • Morgan Stanley first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
  • Morgan Stanley's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1.23M in Q4 2019.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.